HLTH: Dr. David Stein on Revolutionizing Blood Testing: Accessibility and Affordability for All

About David Stein:David Stein is the former global head of strategy and president of molecular diagnostics for Siemens Healthineers. His previous roles include CEO of Siemens' point of care business, head of strategy for the Diagnostics division, and global vice president of engineering within the Diagnostics division. Working alongside Eric Olson, he was instrumental in incubating Babson Diagnostics in the company’s earliest days. David is also the Board Chairman of PixCell Medical, Israel.Dr. Stein earned his Ph.D. in Engineering from Johns Hopkins University.Things You’ll Learn:Babson Diagnostics' BetterWay Blood Testing service allows for routine and specialty testing from a finger prick sample. It is available at convenient locations like pharmacies and community events, which is ideal for people who are afraid of needles or are busy.The service is designed to be affordable, addressing a major barrier for those without insurance or who are underinsured, allowing broader access to vital health information and empowering them with better clinical outcomes.The company actively seeks to partner with local businesses, community groups, and healthcare providers, offering diverse locations and extended hours to serve a wide range of people and impact diverse communities.Blood testing is very personal, and many have stories, good or bad, and a significant percentage don’t get their doctor-ordered blood testing done unless they have a trigger event.Partnering with clinicians is a fundamental human right.Resources:Connect with and follow David Stein on LinkedIn.Follow Babson Diagnostics on LinkedIn and visit their website.Learn more about BetterWay Blood Testing here!